THE GAIN TRIAL: Gemcitabine Alternating with INtravesical BCG randomized against BCG alone for patients with recurrent “BCG-exposed” high grade NMIBC (ALLIANCE A032303/ NCT07000084)
Sunday, May 17, 2026 10:12 AM to 10:20 AM · 8 min. (America/New_York)
Hall B, The Square, Learning Lab
Detail
Oncology: Bladder